ReviewCurrent hematologic malignancy reports2019

Novel Therapies in Myeloproliferative Neoplasms (MPN): Beyond JAK Inhibitors.

Minas P Economides et al.PubMed ↗Publisher ↗

No numbers read from the abstract.